Advertisements

Stocking Stuffers

 

Atossa Genetics Inc. (ATOS) Stock Quote

Detailed Quote for Atossa Genetics Inc. (ATOS)
$ 3.68   -0.05 (-1.34%) Volume: 961.75k 4:00 PM EDT 22-Mar-2019
After Hours:  $ 3.79   0.11 (+2.99%) Volume: 14.03k 7:59 PM EDT 22-Mar-2019
Today 5d 1m 3m 1y more
Last Price
3.68
Change $
0.05
Change %
1.34%
Tick
  
Bid
3.85
Bid Size
2,000
Ask
3.88
Ask Size
800
Open
3.66
High
3.9772
Low
3.58
Prev Close
3.73
Last Trade
03/22/19
Volume
961.75k
52 Wk Hi
7.38999986
52 Wk Low
0.800000011
Market Cap
20.78m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
5,646,552
EPS (TTM)
-4.11999988
PE Ratio
N/A
Exchange
NCM
News and Media for Atossa Genetics Inc. (ATOS)
Sector News | Topic News
News for Atossa Genetics Inc. (ATOS)
Mon, Mar 18, 2019
3:45 PM Atossa Genetics: Expect More Near-Term Positive Catalysts After Continued FDA Approval For One Patient - SeekingAlpha
12:46 PM Healthcare names top midday movers - SeekingAlpha
9:25 AM RIOT, PXLW and ATOS among premarket gainers - SeekingAlpha
8:30 AM Atossa Genetics Announces Receipt of $10 Million - GlobeNewswire
Fri, Mar 15, 2019
3:45 PM Trade Alert: Long Atossa Genetics - SeekingAlpha
12:54 PM Midday Gainers / Losers - SeekingAlpha
9:19 AM KIRK and FRSX among premarket losers - SeekingAlpha
Thu, Mar 14, 2019
6:50 PM Atossa Genetics Soars on FDA Expanded Access Program Approval - Investing News Network
12:44 PM CLDR, TLRD, MDB and WAGE among midday movers - SeekingAlpha
9:27 AM PLUG, TNXP among premarket gainers - SeekingAlpha
8:49 AM Atossa up 227% premarket on expanded access for Endoxifen - SeekingAlpha
8:30 AM Atossa Genetics Announces FDA Approval of Oral Endoxifen for "Expanded Access" as Post-Mastectomy Treatment for a U.S. Breast Cancer Patient - GlobeNewswire
Wed, Feb 27, 2019
6:05 AM "On Fed's Wings" Vista Partners Publishes February 2019's Macroeconomic & Investment Monthly Newsletter - ACCESSWIRE IA
Fri, Feb 08, 2019
9:18 AM VCRA and CARB among premarket losers - SeekingAlpha
Thu, Feb 07, 2019
10:33 AM Atossa up 24% on encouraging Endoxifen data - SeekingAlpha
9:26 AM STI, ATOS among premarket gainers - SeekingAlpha
8:30 AM Atossa Genetics Reports Results From "Expanded Access" Program for a U.S. Breast Cancer Patient Taking Oral Endoxifen: Sizeable Reduction in Cancer Cell Biological Activity; No Safety or Tolerability Issues - GlobeNewswire
Mon, Feb 04, 2019
8:30 AM Atossa Genetics Provides Breast Cancer Prevention Recommendations to the United States Preventative Services Task Force - GlobeNewswire
Wed, Jan 30, 2019
9:15 AM Vista Partners January 2019 Monthly Macroeconomic and Investment Newsletter - ACCESSWIRE IA
More News for ATOS >>
Filings for Atossa Genetics Inc. (ATOS)
Fri, Feb 08, 2019
3:00 AM Amendment to the SC 13G filing - Form SC 13G/A
More Filings for ATOS >>

Tags for Atossa Genetics Inc.

Research stocks or mutual funds related to Atossa Genetics Inc. by keywords or tags. Find companies that have a similar focus to ATOS. The keywords below have been associated to ATOS by either user submission or electronic means.